Volixibat in adults with non-alcoholic steatohepatitis: 24-week interim analysis from a randomized, phase II study
Philip N. Newsome, Melissa Palmer, Bradley Freilich, Muhammad Y. Sheikh, Aasim Sheikh, H Sarles, Robert Herring, Parvez Mantry, Zeid Kayali, Tarek Hassanein, Hak‐Myung Lee, Guruprasad P. Aithal
Topics & Concepts
Internal medicineClinical endpointGastroenterologyMedicineInterim analysisPlaceboTolerabilitySteatohepatitisBile acidFatty liverWeight lossSteatosisEndocrinologyAdverse effectRandomized controlled trialObesityPathologyAlternative medicineDiseaseLiver Disease Diagnosis and TreatmentDrug Transport and Resistance MechanismsLiver Diseases and Immunity